2026 Annual Congress: Hematologic Malignancies
Hosted by National Comprehensive Cancer Network
- 18 – 19 September 2026
- New York Marriott Marquis, New York, United States of America
- Clinical MedicineHaematology, Oncology & Cancer Research
Let others know you'll be there. This does not register you for the event.
Registration
Event has endedRegistration is handled by the organiser
Key facts
2026 Annual Congress: Hematologic Malignancies is a congress held 18 – 19 September 2026 in New York Marriott Marquis, New York, United States of America, organised by National Comprehensive Cancer Network.
- Dates:
- 18 – 19 September 2026
- Format:
- Hybrid (in person and online)
- Venue:
- New York Marriott Marquis, New York, United States of America
- Subjects:
- Haematology, Oncology & Cancer Research
- Organiser:
- National Comprehensive Cancer Network
- Official website:
- nccn.org/hem
The Annual Congress: Hematologic Malignancies, organized by the National Comprehensive Cancer Network, is designed for the entire oncology team to explore treatment options and supportive care for various hematologic malignancies. Chaired by Andrew D. Zelenetz, MD, PhD, the event takes place in New York, New York, with virtual attendance options also available. It offers continuing education credits for physicians, PAs, nurses, pharmacists, and other oncology professionals.
Topics
- Advances in Leukemia Care
- Evolving Lymphoma Treatment Landscape
- Innovations in Cellular and Immune Therapies
- Treatment-Related Toxicity Monitoring and Management
- Plasma Cell Neoplasms
- Myeloid and Rare Hematologic Neoplasms
- Supportive Care and Survivorship
- Interprofessional Collaboration and Care
Who should attend
Designed for the Entire Oncology Team, including physicians, PAs, nurses, pharmacists, and other oncology professionals.
Organising Committee
Chair: Andrew D. Zelenetz, MD, PhD, Memorial Sloan Kettering Cancer Center.
Programme highlights
View full programmeSpeakers
View all 26 speakersJohns Hopkins Kimmel Cancer Center
Collaborative Strategies for Optimizing Small-Volume Drug DeliveryAbramson Cancer Center at the University of Pennsylvania
Current and Emerging Treatment Options for Peripheral T-Cell LymphomasMemorial Sloan Kettering Cancer Center
Working Toward Unified Classification of Hematolymphoid MalignanciesUCSF Helen Diller Family Comprehensive Cancer Center
Update on the Diagnosis and Management of Marginal Zone LymphomasJohns Hopkins Kimmel Cancer Center
Opening Remarks and Outpatient Administration of Bispecific Antibodies and CAR T-Cell TherapiesJohns Hopkins Kimmel Cancer Center
The Role of Clonal Hematopoiesis in Hematologic MalignanciesMemorial Sloan Kettering Cancer Center
Managing Toxicities of Bispecific Antibodies and CAR T-Cell Therapies in the Outpatient SettingRoswell Park Comprehensive Cancer Center
Chronic Lymphocytic Leukemia: Navigating First-Line and MRD-Guided Treatment Options
Organiser and contact
Host organisation
National Comprehensive Cancer NetworkContact
- Email:
- [email protected]
Advertisement
Related events
- International Kidney Cancer Symposium (IKCS): North America 2026Dallas, United States of America19–21 Nov 2026
- San Antonio Breast Cancer Symposium® | SABCS 2026San Antonio, United States of America8–11 Dec 2026
- 68th ASH Annual Meeting and ExpositionNew Orleans, United States of America12–15 Dec 2026
- Mayo Clinic Radiation Oncology: Current Practice and Future DirectionLahaina, United States of America11–15 Jan 2027
- SGO 2027 Annual Meeting on Gynecologic CancerPhoenix, United States of America19–22 Mar 2027
- ESMO Congress 2026Madrid, Spain23–27 Oct 2026